Press Releases

Flexible containment specialist ONFAB appoints new business lead to drive European growth

Francis Dechoux will focus on growth opportunities across the EMEA region

Flexible containment specialist ONFAB, part of the Envair Technology group, has appointed Francis Dechoux as its new European Business Lead.
Francis will support ONFAB’s continuing growth within the pharmaceutical industry focussing on key European territories, including France, Germany, and Spain.

His role will see him take a strategic lead, helping to raise awareness and acceptance of ONFAB’s transformational flexible containment technology within the industry.
Fluent in three languages, Francis has over 30 years of experience working in business development roles with global manufacturers, mainly in the automotive industry at Mitras Automotive.

Francis said: “It’s an exciting time to be joining ONFAB. The level of growth the business is experiencing across Europe is impressive. I’m looking forward to working with customers to help them take advantage of its innovative containment solutions.”

Mark Arnold, Managing Director of ONFAB said: “With more pharmaceutical businesses using highly potent compounds, we’re seeing a huge growth in demand for flexible containment that will protect operators and prevent cross-contamination. Francis’s wealth of experience in supporting global manufacturers will be valuable as we look to onboard an increasing number of customers in Europe.”

About Envair Technology
Envair Technology was formed following the acquisition of Envair Limited by ONFAB in 2019 and Total Containment Solutions (TCS) in 2020. The group brings world class design and manufacturing expertise in clean air and containment to organisations developing or manufacturing drugs and new therapies around the world.
Working with hospitals and healthcare settings, pharmaceutical firms and R&D laboratories, the group offers a wide portfolio of products and services that protect the safety of teams handling hazardous compounds and maintain the integrity of pharmaceutical products.